NuScale Power Stock Faces Valuation Hurdles Amid Technology Commercialization Push

The Motley FoolThe Motley Fool
|||1 min read
Key Takeaway

NuScale Power gains NRC approval for SMR technology but faces high valuation at 70x sales with no commercial deployment yet, making it a speculative pre-revenue investment.

NuScale Power Stock Faces Valuation Hurdles Amid Technology Commercialization Push

NuScale Power Corp. is advancing its small modular reactor (SMR) technology with regulatory approval from the Nuclear Regulatory Commission, positioning the company to serve emerging demand from data centers and industrial applications. The company's design represents a significant development in nuclear innovation; however, NuScale has yet to achieve commercial project deployment and currently operates at a net loss while consuming cash reserves.

The company's valuation presents a notable consideration for potential investors, trading at over 70 times sales—a multiple that reflects substantial future growth expectations relative to current revenue generation. This valuation premium underscores the speculative nature of the investment, as the path to profitability depends on successful commercialization of its SMR technology and securing customer contracts.

Analysts have noted that investors with lower risk tolerance or those seeking nuclear sector exposure may find alternative options more suitable, such as diversified nuclear-focused exchange-traded funds that provide broader market participation without concentration risk in a single pre-revenue technology company.

Source: The Motley Fool

Back to newsPublished Feb 15

Related Coverage

The Motley Fool

Nvidia's $3.2B Corning Investment Powers AI Boom—But Stock Valuation Raises Caution

Corning partners with Nvidia on $3.2B optical component deal for AI data centers. Stock surged 315% in 12 months, trading at 60x forward earnings amid strong fundamentals.

NVDAMETAGLW
The Motley Fool

Nuclear Renaissance Accelerates: Which Stocks Offer Best Risk-Return Profile

Nuclear power renaissance sparks investor interest across risk spectrum, with established uranium producers and emerging reactor developers offering distinct opportunities for conservative and aggressive investors.

SMROKLOCCJ
The Motley Fool

NuScale's 82% Crash Opens Recovery Bet—But SMR Timeline Poses Real Risk

NuScale stock plunged 82% from October peak. Morgan Stanley data shows 49% of 80-85% crash stocks recover within 4.2 years, but execution risks loom large.

SMRNVDA
The Motley Fool

Amazon's AI Bet: Why Free Cash Flow Could Turn Negative in 2026

Amazon's free cash flow expected to turn negative in 2026 as the company aggressively invests billions in AI data center infrastructure to compete in the booming cloud market.

AMZN
The Motley Fool

Can Nvidia Reach $10 Trillion? Path to Historic Valuation Hinges on AI Dominance

Nvidia could become first $10 trillion company within three years if it sustains AI growth, requiring $600B revenue and $333B net income based on analyst projections.

NVDA
The Motley Fool

Medtronic's Dividend Fortress Rivals Intuitive Surgical's Growth at Half the Price

Medtronic offers a more attractive valuation (22x P/E vs. 55x) than Intuitive Surgical, with 3.6% dividend yield and Hugo robot growth potential.

MDTISRG